Tempus AI: The Diagnostics CEO Sells 17,314 Shares for $929,990

Thomas Edward Schoenherr, Diagnostics CEO of Tempus AI, Inc. (TEM), sold 17,314 shares of the company on August 21, 2026, for a total value of $929,990 at a price of $61.23 per share, according to a regulatory filing with the SEC (Form 4).

Who is Thomas Schoenherr and What is His Real Role at Tempus AI

Thomas Schoenherr serves as the Diagnostics CEO at Tempus AI, a company specializing in artificial intelligence applied to precision medicine. In this role, he is responsible for the diagnostics division of the company, which develops and commercializes genomic tests and data analysis tools for healthcare professionals.

This executive position grants him access to privileged information regarding the company's financial performance, product launches, strategic partnerships, and business outlook for the diagnostics division. Consequently, executives' transactions are closely monitored by investors, as they may reflect their confidence in the company's future.

Tempus AI is listed under the ticker TEM and was founded in 2015. The company leverages artificial intelligence to analyze clinical and molecular data to help physicians make more informed decisions. The Diagnostics division is a central pillar of its business model.

Transaction Details: 17,314 Shares at $61.23 Each

The Form 4 filing with the SEC indicates that Thomas Schoenherr sold 17,314 shares of Tempus AI on August 21, 2026, at a price of $61.23 per share, totaling $929,990. It's important to note that the per-share price and total value are distinct figures: the former represents the unit price, while the latter reflects the overall transaction amount.

This sale was executed in a single transaction, as shown in the filing. The filing was made within two business days of the transaction, complying with SEC regulations requiring executives of publicly traded companies to disclose their stock transactions within this timeframe.

The Form 4 is accessible to the public on the SEC's website, allowing investors to track insider movements. In this case, the sale involved approximately 17,314 shares, which is a significant number for an executive but difficult to judge as unusual without knowing the insider's total portfolio.

Why Insiders Sell Their Shares – Possible Reasons

Share sales by insiders can be motivated by multiple factors. Diversification is one of the most common reasons: executives often concentrate a large portion of their wealth in their company's stock, and selling allows them to rebalance their portfolio and reduce risk.

Tax planning may also play a role. Insiders might sell shares to pay taxes owed on stock options or restricted stock units. Additionally, they may need liquidity for personal expenses, such as purchasing real estate or funding projects.

It's important not to interpret a sale as a definitive bearish signal. Insiders may sell for personal reasons unrelated to the company's health. However, investors monitor these transactions because they can sometimes indicate a lack of confidence in short-term prospects. In this case, the signal is considered bearish, but caution is advised.

How Individual Investors Track Form 4 Filings

Form 4 filings are available for free on the SEC's official database, EDGAR. Investors can use this resource to monitor insider activity and stay informed about potential market-moving developments.